Quality Assurance Technician – Parenteral (m/w/d) at Eli Lilly and Company

Alzey, Rhineland-Palatinate, Germany

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
PharmaceuticalsIndustries

Requirements

  • (Not explicitly listed in the job description; focus is on responsibilities and role fit for motivated individuals with relevant experience in quality assurance, GMP, and parenteral production.)

Responsibilities

  • Ensure a safe working environment and safe working practices; support all health, safety, and environmental goals of the company and site
  • Act as the main point of contact for internal/external customers and answer general information requests in your area of expertise
  • Train and coach operations and support personnel on quality issues
  • Support production activities on-site with regular presence in the assigned production area
  • Follow good documentation practices and adhere to site procedures
  • Capture, review, maintain, and approve GMP information/data in the appropriate systems and within specified deadlines (e.g., electronic batch documents, logbooks, etc.)
  • Design, revise, and archive standard operating procedures as well as associated forms and training materials in your area of expertise
  • Support the resolution of equipment alarms and other issues in quality systems such as Veeva and MES
  • Make initial decisions on deviations in production areas and escalate as needed
  • Support batch release and participate in deviation investigations
  • Create, review, and approve GMP documents; review batch documentation
  • Ensure compliance with GMP requirements through on-site quality monitoring in key areas: material/equipment preparation, formulation and aseptic filling, visual inspection

Skills

Quality Assurance
Parenteral Manufacturing
GMP
Facility Qualification
Pharmaceutical Production
Aseptic Processing
Validation

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI